Stay updated on Aducanumab in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.6.2, indicating a newer page revision. This reflects an internal update to the documentation rather than changes to the study details.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading formatting was updated. The revision tag was updated to v3.6.0.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page's revision history now shows a new revision entry (v3.5.5) and removes the previous revision (v3.5.4), indicating an updated page version.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays an updated revision label (v3.5.4) replacing the previous v3.5.3, indicating a newer page revision without changing substantive study content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan, Taiwan, 333 to Taoyuan County, Taiwan, 333, correcting the locality naming in the study's Contacts and Locations section. This change clarifies the geographic location of the site in the trial's location list.SummaryDifference0.0%

- Check67 days agoChange DetectedUpdates the displayed site revision identifier from **v3.5.2** to **v3.5.3** on the page footer.SummaryDifference0.0%

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.